4
Changes in Ownership
IRONWOOD PHARMACEUTICALS INC Filed Acc 0001193125-26-071503
SVP, CMO, Head-Res&Drug sold 17,012 shares at $3.66 ($62,264)
- SVP, CMO, Head-Res&Drug sold 15,570 shares at $3.81 ($59,322)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Shetzline Michael SVP, CMO, Head-Res&Drug | 2026-02-23 | Sale | −15,570 | $3.81 | $59,322 | 538,437 | D |
| Shetzline Michael SVP, CMO, Head-Res&Drug | 2026-02-24 | Sale | +17,012 | $3.66 | $62,264 | 521,425 | D |
| Open-market sales · 32,582 sh · avg $3.73 · $121,586 | |||||||
Loading xslF345X05/ownership.xml…